Amperos Health Secures $16M to Tackle Healthcare Claims Denials with AI

Amperos Health, a startup focused on denial management and revenue recovery for healthcare providers, has secured $16 million in Series A funding. This investment underscores the growing urgency and market opportunity in addressing the pervasive issue of denied claims, which cost providers billions annually.

Why it Matters

In 2024, approximately 12% of healthcare claims were denied, resulting in a staggering $262 billion in lost revenue for providers. The recovery process is both costly and inefficient, with providers spending about $26 billion each year to recoup denied claims, yet only managing to recover around 70% of these amounts.

Amperos Health aims to transform this landscape by leveraging artificial intelligence (AI) to streamline the denial management process. Their AI platform integrates seamlessly into existing billing systems, acting as an extension of the provider's team rather than a separate tool. This approach not only reduces operational costs but also enhances revenue recovery efficiency.

The Solution

Amperos’ AI-native platform automates the entire workflow associated with denied claims, including follow-ups, appeals, calls, and paperwork. By handling these tasks autonomously, the platform allows providers to focus on patient care while ensuring that billing processes are optimized for maximum reimbursement.

Michal Miernowski, CEO of Amperos Health, emphasized the platform's unique value proposition: “The AI that Amperos uses works directly within the provider’s existing billing software, acting like a member of their team rather than a separate platform to manage. The result is that providers recover more revenue, at lower cost, without hiring more staff.”

Key Risks

Despite the promising technology and market need, several risks remain:

1. Implementation Challenges: Integrating AI into legacy systems can be complex and may require significant IT resources.
2. Regulatory Hurdles: The healthcare industry is heavily regulated, and ensuring compliance with various state and federal regulations could pose a challenge.
3. Market Adoption: Convincing providers to adopt new technology, especially in an already resource-constrained environment, may take time.

The Opportunity

The potential for Amperos Health is substantial. With the Series A funding led by Bessemer Venture Partners, along with participation from Uncork Capital and Neo, the company plans to expand its team and services. Currently, Amperos supports outpatient clinics and physician group practices across all 50 states, with a focus on specialties such as orthopedics, ophthalmology, durable medical equipment, dermatology, and behavioral health.

Sofia Guerra, partner at Bessemer Venture Partners, highlighted the market opportunity: “Denials are one of healthcare’s fastest-growing pain points: a growing portion of claims denied, hundreds of billions in lost revenue, and RCM teams that are chronically understaffed. It’s a broken process ripe for AI transformation.”

Looking Ahead

With its latest funding round, Amperos Health is well-positioned to address the critical issue of denied claims in healthcare. By leveraging advanced AI, the company aims to provide a scalable solution that not only improves financial outcomes for providers but also enhances the overall efficiency and effectiveness of the healthcare system.